Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients with Type 2 Diabetes: A Randomized Trial

RATIONALE & OBJECTIVE: Hyperuricemia is implicated in the development and progression of chronic kidney disease (CKD). Verinurad is a novel, potent, specific urate reabsorption inhibitor. We evaluated the effects of intensive urate-lowering therapy with verinurad combined with the xanthine oxida...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Kidney Dis
Main Authors: Stack, Austin G., Dronamraju, Nalina, Parkinson, Joanna, Johansson, Susanne, Johnsson, Eva, Erlandsson, Fredrik, Terkeltaub, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045740/
https://ncbi.nlm.nih.gov/pubmed/33130235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2020.09.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados